Dashboard
Manage Tickers

JNJJOHNSON & JOHNSON

NYSE jnj.com


$ 144.60 $ -2.22 (-1.51 %)    

Tuesday, 30-Apr-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 423.46 $ -8.80 (-2.04 %)
DIA $ 377.96 $ -4.26 (-1.11 %)
SPY $ 501.59 $ -6.32 (-1.24 %)
TLT $ 88.19 $ -0.28 (-0.32 %)
GLD $ 211.99 $ -4.19 (-1.94 %)
$ 144.59
$ 146.72
$ 0.00 x 0
$ 0.00 x 0
$ 144.54 - $ 146.72
$ 142.71 - $ 172.01
6,461,588
na
375.92B
$ 0.49
$ 10.69
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-16-2024 12-31-2023 10-K
2 10-27-2023 10-01-2023 10-Q
3 10-27-2023 10-01-2023 10-Q
4 07-31-2023 07-02-2023 10-Q
5 04-28-2023 04-02-2023 10-Q
6 02-16-2023 01-01-2023 10-K
7 10-27-2022 10-02-2022 10-Q
8 07-29-2022 07-03-2022 10-Q
9 04-29-2022 04-03-2022 10-Q
10 02-17-2022 01-02-2022 10-K
11 10-29-2021 10-03-2021 10-Q
12 07-29-2021 07-04-2021 10-Q
13 04-30-2021 04-04-2021 10-Q
14 02-22-2021 01-03-2021 10-K
15 10-23-2020 09-27-2020 10-Q
16 07-24-2020 06-28-2020 10-Q
17 04-29-2020 03-29-2020 10-Q
18 02-18-2020 12-29-2019 10-K
19 10-28-2019 09-29-2019 10-Q
20 07-29-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 02-20-2019 12-30-2018 10-K
23 10-31-2018 09-30-2018 10-Q
24 08-02-2018 07-01-2018 10-Q
25 05-01-2018 04-01-2018 10-Q
26 02-21-2018 12-31-2017 10-K
27 11-02-2017 10-01-2017 10-Q
28 08-03-2017 07-02-2017 10-Q
29 05-08-2017 04-02-2017 10-Q
30 02-27-2017 01-01-2017 10-K
31 11-04-2016 10-02-2016 10-Q
32 08-04-2016 07-03-2016 10-Q
33 05-10-2016 04-03-2016 10-Q
34 02-24-2016 01-03-2016 10-K
35 10-30-2015 09-27-2015 10-Q
36 07-31-2015 06-28-2015 10-Q
37 05-01-2015 03-29-2015 10-Q
38 02-24-2015 12-28-2014 10-K
39 10-30-2014 09-28-2014 10-Q
40 08-01-2014 06-29-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

spotlight-on-johnson--johnson-analyzing-the-surge-in-options-activity
Spotlight on Johnson & Johnson: Analyzing ...
04/30/2024 18:46:29

johnson--johnson-partnered-addex-therapeutics-epilepsy-candidate-fails-mid-stage-study-stock-tanks
Johnson & Johnson-Partnered Addex Therapeu...
04/29/2024 14:53:51

Latest Phase 2 epilepsy study findings on ADX71149 adjunctive therapy for focal onset seizures. Partnered with Janssen, Addex T...

jj-says-chmp-recommends-conversion-of-conditional-marketing-authorization-for-sirturo-bedaquiline-into-standard-marketing-authorization
J&J Says CHMP Recommends Conversion Of Con...
04/29/2024 14:19:45

- Reuters

johnson--johnson-receives-positive-chmp-opinion-recommending-full-approval-for-sirturo-for-treatment-of-multidrug-resistant-tuberculosis
Johnson & Johnson Receives Positive CHMP O...
04/29/2024 14:17:48

- Reuters

Core News & Articles
Cidara Therapeutics Reacquires Global Deve...
04/24/2024 20:47:52

- $240 million private placement financing led by RA Capital Management with significant participation by Bain Capital Life Sci...

johnson--johnson-childrens-cough-syrup-contaminated-in-some-batches---who-poised-to-issue-global-alert-updated
Johnson & Johnson Children's Cough Syrup C...
04/23/2024 20:21:54

WHO alerts the global community about tainted children's cough syrup by Johnson & Johnson. Elevated toxin levels detect...

ec-approved-carvykti-for-treatment-of-relapsedrefractory-multiple-myeloma
EC Approved Carvykti For Treatment Of Rela...
04/22/2024 11:57:29

-Bloomberg

brexit-impact-on-drugs---rising-shortages-in-uk-highlight-brexit-challenges
Brexit Impact On Drugs - Rising Shortages ...
04/19/2024 15:39:26

Discover the impact of Brexit on UK drug shortages. Insights from a recent Nuffield Trust study reveal a doubling in shortages ...

fda-mandates-boxed-warning-for-bristol-myers-johnson--johnson-car-t-based-blood-cancer-therapies
FDA Mandates "Boxed Warning" For Bristol M...
04/19/2024 13:28:52

Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings—t...

hsbc-upgrades-johnson--johnson-to-buy-raises-price-target-to-170
HSBC Upgrades Johnson & Johnson to Buy, Ra...
04/18/2024 15:41:33

HSBC analyst Morten Herholdt upgrades Johnson & Johnson (NYSE:JNJ) from Hold to Buy and raises the price target from $16...

unpacking-the-latest-options-trading-trends-in-johnson--johnson
Unpacking the Latest Options Trading Trend...
04/18/2024 14:32:29

johnson--johnson-shares-hold-steady-after-q1-earnings-analysts-optimistic-about-future
Johnson & Johnson Shares Hold Steady After...
04/17/2024 19:37:34

Johnson & Johnson reports first-quarter earnings, with adjusted EPS up 12.4% and sales up 2.3%. Analysts optimistic about s...

johnson--johnson-analysts-cut-their-forecasts-after-q1-results
Johnson & Johnson Analysts Cut Their Forec...
04/17/2024 17:51:23

Johnson & Johnson (NYSE: JNJ) reported better-than-expected first-quarter earnings on Tuesday.

rbc-capital-maintains-outperform-on-johnson--johnson-lowers-price-target-to-175
RBC Capital Maintains Outperform on Johnso...
04/17/2024 17:11:42

RBC Capital analyst Shagun Singh maintains Johnson & Johnson (NYSE:JNJ) with a Outperform and lowers the price target fr...

cantor-fitzgerald-reiterates-overweight-on-johnson--johnson-maintains-215-price-target
Cantor Fitzgerald Reiterates Overweight on...
04/17/2024 13:28:36

Cantor Fitzgerald analyst Louise Chen reiterates Johnson & Johnson (NYSE:JNJ) with a Overweight and maintains $215 price...

visa-to-rally-around-18-here-are-10-top-analyst-forecasts-for-wednesday
Visa To Rally Around 18%? Here Are 10 Top ...
04/17/2024 12:21:44

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

b-of-a-securities-maintains-neutral-on-johnson--johnson-lowers-price-target-to-170
B of A Securities Maintains Neutral on Joh...
04/17/2024 10:33:08

B of A Securities analyst Geoff Meacham maintains Johnson & Johnson (NYSE:JNJ) with a Neutral and lowers the price targe...

stocks-grapple-with-geopolitical-pressures-gold-eyes-2400-bitcoin-falls-below-62000-whats-driving-markets-tuesday
Stocks Grapple With Geopolitical Pressures...
04/16/2024 17:28:14

Investors remain on edge as geopolitics continue to shape market trends, with Israel mulling a response to Iran while the U.S. ...

johnson--johnson-shows-focus-on-strengthening-its-business-upon-its-consumer-health-unit-spinoff
Johnson & Johnson Shows Focus On Strengthe...
04/16/2024 15:49:17

On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estima...

johnson--johnson-q1-earnings-top-wall-street-estimates-on-strong-medical-devices-sales-drugmaker-boosts-annual-outlook
Johnson & Johnson Q1 Earnings Top Wall Str...
04/16/2024 13:29:10

Johnson & Johnson reports Q1 results: adjusted EPS $2.71 (up 12.4% Y/Y), sales $21.38B (up 2.3% Y/Y). Explore pharma giant&...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION